scholarly journals The role of exosomal long non-coding RNAs in cancer drug resistance

2019 ◽  
Author(s):  
Mireia Cruz De los Santos ◽  
Mihnea P. Dragomir ◽  
George A. Calin
Keyword(s):  
Drug Resistance ◽  
Cancer Drug ◽  
Cancer Drug Resistance ◽  
Non Coding Rnas

scholarly journals Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives

2012 ◽  
Vol 4 (8) ◽  
pp. 675-684 ◽  
Author(s):  
Nicholas A. Saunders ◽  
Fiona Simpson ◽  
Erik W. Thompson ◽  
Michelle M. Hill ◽  
Liliana Endo‐Munoz ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Cancer Drug ◽  
Cancer Drug Resistance ◽  
Intratumoural Heterogeneity

scholarly journals Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

2012 ◽  
Vol 83 (8) ◽  
pp. 1084-1103 ◽  
Author(s):  
Karthika Natarajan ◽  
Yi Xie ◽  
Maria R. Baer ◽  
Douglas D. Ross
Keyword(s):  
Breast Cancer ◽  
Drug Resistance ◽  
Breast Cancer Resistance Protein ◽  
Cancer Drug ◽  
Cancer Resistance ◽  
Cancer Drug Resistance ◽  
Resistance Protein

scholarly journals The role of photodynamic therapy in overcoming cancer drug resistance

2015 ◽  
Vol 14 (8) ◽  
pp. 1476-1491 ◽  
Author(s):  
Bryan Q. Spring ◽  
Imran Rizvi ◽  
Nan Xu ◽  
Tayyaba Hasan
Keyword(s):  
Drug Resistance ◽  
Photodynamic Therapy ◽  
Cancer Cells ◽  
Cancer Drug ◽  
Cancer Drug Resistance

This perspective highlights unique mechanisms of photodynamic therapy (PDT) that can be utilized to overcome classical drug resistance and re-sensitize resistant cancer cells for standard therapies.

The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance

2013 ◽  
Vol 67 (7) ◽  
pp. 669-680 ◽  
Author(s):  
Radosław Januchowski ◽  
Karolina Wojtowicz ◽  
Maciej Zabel
Keyword(s):  
Drug Resistance ◽  
Aldehyde Dehydrogenase ◽  
Cancer Drug ◽  
Cancer Drug Resistance

Cancer drug resistance: The central role of the karyotype☆

2007 ◽  
Vol 10 (1-2) ◽  
pp. 51-58 ◽  
Author(s):  
P DUESBERG ◽  
R LI ◽  
R SACHS ◽  
A FABARIUS ◽  
M UPENDER ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Cancer Drug ◽  
Cancer Drug Resistance

The role of deubiquitinating enzymes in cancer drug resistance

2020 ◽  
Vol 85 (4) ◽  
pp. 627-639
Author(s):  
Parthasaradhireddy Tanguturi ◽  
Kye-Seong Kim ◽  
Suresh Ramakrishna
Keyword(s):  
Drug Resistance ◽  
Cancer Drug ◽  
Deubiquitinating Enzymes ◽  
Cancer Drug Resistance

scholarly journals The role of galectin-3 in cancer drug resistance

2007 ◽  
Vol 10 (3) ◽  
pp. 101-108 ◽  
Author(s):  
Tomoharu Fukumori ◽  
Hiro-omi Kanayama ◽  
Avraham Raz
Keyword(s):  
Drug Resistance ◽  
Cancer Drug ◽  
Cancer Drug Resistance ◽  
Galectin 3

scholarly journals The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance

2021 ◽  
Author(s):  
Jihye Seo ◽  
Jain Ha ◽  
Eunjeong Kang ◽  
Sayeon Cho
Keyword(s):  
Drug Resistance ◽  
Transcription Factors ◽  
Epithelial Mesenchymal Transition ◽  
Cancer Drug ◽  
Preclinical Studies ◽  
Mesenchymal Transition ◽  
Cancer Drug Resistance ◽  
Anti Cancer ◽  
Future Challenges

AbstractThe complex orchestration of gene expression that mediates the transition of epithelial cells into mesenchymal cells is implicated in cancer development and metastasis. As the primary regulator of the process, epithelial-mesenchymal transition-regulating transcription factors (EMT-TFs) play key roles in metastasis. They are also highlighted in recent preclinical studies on resistance to cancer therapy. This review describes the role of three main EMT-TFs, including Snail, Twist1, and zinc-finger E homeobox-binding 1 (ZEB1), relating to drug resistance and current possible approaches for future challenges targeting EMT-TFs.

Sign in / Sign up

Export Citation Format

Share Document